Ethylenediamine

Ethylenediamine

SCHEMBL3287281

Cl.NCCN.NCCN.[Pt]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
BLM P54132 2/20 0.46
NFKB1 P19838 1/20 0.40
EHMT2 Q96KQ7 1/20 0.39
TSHR P16473 3/20 0.36
DNM1 Q05193 3/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA3 P07451 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA5A P35218 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CA5B Q9Y2D0 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL5438151 1.00
Ethylenediamine SCHEMBL11229397 0.93 MAPT (0.50) MAPTTDP1ALDH1A1LMNABLM
Ethylenediamine SCHEMBL8414481 0.93
Ethylenediamine SCHEMBL4840713 0.93 NFKB1 (0.44) MAPTTDP1ALDH1A1LMNABLM
Ethylenediamine SCHEMBL11440118 0.93 MAPT (0.50) MAPTTDP1ALDH1A1LMNABLM
Ethylenediamine SCHEMBL1331588 0.93
Ethylenediamine SCHEMBL371485 0.93
Ethylenediamine SCHEMBL5085636 0.93
Ethylenediamine SCHEMBL5147148 0.93 NFKB1 (0.44) MAPTTDP1ALDH1A1LMNABLM
Ethylenediamine SCHEMBL607065 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718803-B2 Self-dispersible bipyridine-based metal complex and ink composition comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-05-18 US disclosed
US-7396399-B2 Bipyridine-based metal complex and ink composition comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-07-08 US disclosed
US-20070269991-A1 SEMICONDUCTOR NANOCRYSTAL-METAL COMPLEX AND METHOD OF PREPARING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-11-22 US disclosed
US-20050033040-A1 Self-dispersible bipyridine-based metal complex and ink composition comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2005-02-10 US disclosed
US-20050033053-A1 Bipyridine-based metal complex and ink composition comprising the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2005-02-10 US disclosed
US-20040102654-A1 Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use SPAGNOL MICHEL (FR) 2004-05-27 US disclosed
US-20020120169-A1 Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use SPAGNOL MICHEL (FR) 2002-08-29 US disclosed
EP-0716931-B1 Ink and sheet for ink jet recording and ink recording method KONISHIROKU PHOTO IND (JP) 2001-10-24 EP disclosed
US-5706042-A CHELATION OF AZO OR INDOANILINE DYES WITH METAL, COLORFAST KONICA CORPORATION (JP) 1998-01-06 US disclosed
EP-0716931-A1 Ink and sheet for ink jet recording and ink recording method KONICA CORPORATION (JP) 1996-06-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033040-A1 Self-dispersible bipyridine-based metal complex and ink composition comprising the same PDCD2L, BICRA, BRD1 MAPT 1373/4885TDP1 3932/4885ALDH1A1 1418/4885
US-20050033053-A1 Bipyridine-based metal complex and ink composition comprising the same TP53, BCCIP, CIP2A MAPT 572/4885TDP1 2787/4885ALDH1A1 1475/4885
US-20020120169-A1 Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use AFF4, APEH, TECR MAPT 4506/4885TDP1 4544/4885ALDH1A1 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.